34.03
                                            Dianthus Therapeutics Inc Aktie (DNTH) Neueste Nachrichten
Dianthus Therapeutics Reports Positive Phase 2 Results - TipRanks
Dianthus Therapeutics, Inc. Updates Corporate Presentation - TradingView
Will Dianthus Therapeutics Inc. stock see PE expansionWeekly Market Outlook & Daily Profit Focused Screening - newser.com
How Dianthus Therapeutics Inc. stock reacts to global recession fearsMarket Growth Report & Smart Allocation Stock Tips - newser.com
Is Dianthus Therapeutics Inc. (87E) stock a fit for income portfoliosNew Guidance & Breakout Confirmation Trade Signals - newser.com
Trend analysis for Dianthus Therapeutics Inc. this weekJuly 2025 Sentiment & Scalable Portfolio Growth Ideas - newser.com
Smart tools for monitoring Dianthus Therapeutics Inc.’s price actionRate Hike & Growth Oriented Trading Recommendations - newser.com
What recovery options are there for Dianthus Therapeutics Inc.July 2025 Final Week & Free Community Consensus Stock Picks - newser.com
Why Dianthus Therapeutics Inc. stock remains resilientDay Trade & Weekly Market Pulse Updates - newser.com
Will Dianthus Therapeutics Inc. (87E) stock hit Wall Street targetsJuly 2025 Sentiment & Entry Point Confirmation Alerts - newser.com
How to escape a deep drawdown in Dianthus Therapeutics Inc.Gap Up & Growth Focused Stock Reports - newser.com
Will Dianthus Therapeutics Inc. (87E) stock outperform value peersJuly 2025 Pullbacks & Daily Market Momentum Tracking - newser.com
Using Python tools to backtest Dianthus Therapeutics Inc. strategiesJuly 2025 Opening Moves & Risk Controlled Swing Trade Alerts - newser.com
Will Dianthus Therapeutics Inc. (87E) stock gain from green policiesMarket Risk Summary & Expert Verified Movement Alerts - newser.com
Long term hold vs stop loss in Dianthus Therapeutics Inc.2025 Momentum Check & Fast Moving Stock Watchlists - newser.com
Dianthus Therapeutics Inc. stock chart pattern explainedMarket Risk Report & Community Trade Idea Sharing Platform - newser.com
Using Bollinger Bands to evaluate Dianthus Therapeutics Inc.July 2025 Review & AI Optimized Trade Strategies - newser.com
Can Dianthus Therapeutics Inc. stock hit analyst price targetsWeekly Gains Report & Verified Momentum Stock Alerts - newser.com
Dianthus Therapeutics, Inc. (DNTH) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Using economic indicators to assess Dianthus Therapeutics Inc. potentialWeekly Gains Summary & Risk Managed Trade Strategies - newser.com
Dianthus Therapeutics (DNTH) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
What to expect from Dianthus Therapeutics Inc. in the next 30 daysJuly 2025 WrapUp & Daily Entry Point Trade Alerts - newser.com
How to monitor Dianthus Therapeutics Inc. with trend dashboardsWeekly Trend Summary & Risk Controlled Daily Trade Plans - newser.com
Dianthus Therapeutics, Inc. (DNTH) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Dianthus Therapeutics, Inc. (DNTH) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance
How New Phase 2 MaGic Data on Claseprubart Has Changed the Investment Story at Dianthus Therapeutics (DNTH) - Sahm
Dianthus Therapeutics Highlights New Claseprubart Data Presented During 2025 AANEM Annual Meeting - The Manila Times
Dianthus Therapeutics Reports Positive Phase 2 MaGic Trial Data for Claseprubart in Generalized Myasthenia Gravis and Plans Phase 3 Trial Initiation in 2026 - Quiver Quantitative
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):